戻る
Transmedics Group Inc (TMDX)価格
TMDX 株価推移チャート
TMDX 収入
Transmedics Group Inc
$143.37
-0.22%
$-0.31
終値： Jan 16, 16:00:00 GMT-5
$142.5
-0.6%
$-0.87
アフターマーケット：Jan 16, 20:00:00 GMT-5
主要データ
前終値
$143.69
始値
$143.51
当日レンジ
$140.41 - $149.22
52週レンジ
$55 - $156
取引高
813.4K
平均取引高
863.5K
1株当たり利益(TTM)
2.30
配当利回り
--
時価総額
$4.8B
TMDXとは何ですか？
TransMedics Group, Inc. operates as a commercial stage medical technology company. The company is headquartered in Andover, Massachusetts and currently employs 728 full-time employees. The company went IPO on 2019-05-02. The firm specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. The company also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.